IOVA

Iovance Biotherapeutics Inc

Jun 17 • 12:29PM ET

4.05

+0.23 6.15 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: RCUS TNGX CGON KYMR NUVL RYTM BMRN INCY KRYS LKFT

| Held by: VTI XBI IWM VB VXF VBR IWN IBB VTWO SCHA

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-0.95	Insider Own	13.13%	Shs Outstand	438.11M	Perf Week	7.28%
Market Cap	1.81B	Forward P/E	-	EPS next Y	-0.31	Insider Trans	0.00%	Shs Float	387.87M	Perf Month	19.62%
Enterprise Value	1.54B	PEG	-	EPS next Q	-0.13	Inst Own	54.36%	Short Float	26.88%	Perf Quarter	7.56%
Income	-353.86M	P/S	6.34	EPS this Y	49.60%	Inst Trans	1.25%	Short Ratio	7.41	Perf Half Y	87.73%
Sales	285.55M	P/B	2.46	EPS next Y	43.74%	ROA	-37.40%	Short Interest	104.25M	Perf YTD	48.53%
Book/sh	1.65	P/C	5.78	EPS next 5Y	-	ROE	-47.51%	52W High	5.63 -27.98%	Perf Year	100.74%
Cash/sh	0.70	P/FCF	-	EPS past 3/5Y	23.93% 10.23%	ROIC	-46.22%	52W Low	1.66 144.28%	Perf 3Y	-50.06%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	25.04%	Volatility	7.79% 8.71%	Perf 5Y	-83.53%
Dividend TTM	-	EV/Sales	5.41	EPS Y/Y TTM	23.00%	Oper. Margin	-125.41%	ATR (14)	0.33	Perf 10Y	-46.08%
Dividend Ex-Date	-	Quick Ratio	3.15	Sales Y/Y TTM	34.26%	Profit Margin	-123.92%	RSI (14)	53.14	Recom	1.50
Dividend Gr. 3/5Y	- -	Current Ratio	3.60	EPS Q/Q	47.50%	SMA20	1.02%	Beta	0.71	Target Price	8.80
Payout	-	Debt/Eq	0.07	Sales Q/Q	44.82%	SMA50	7.45%	Rel Volume	0.80	Prev Close	3.82
Employees	975	LT Debt/Eq	0.06	Earnings	May 07 BMO	SMA200	36.96%	Avg Volume	14.07M	Price	4.05
IPO	Sep 01, 2009	Option/Short	Yes / Yes	EPS/Sales Surpr.	-23.70% -8.23%	Trades		Volume	5,503,630	Change	6.15%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)